| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |